New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

Published Date: 21 Jun 2024

All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

2.

The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.

3.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

4.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

5.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot